Cyclosporine-associated facial paralysis in a child with renal transplant

Pediatr Nephrol. 2002 Jul;17(7):544-6. doi: 10.1007/s00467-002-0924-0. Epub 2002 Jun 18.

Abstract

Cyclosporine (CsA)-associated neurotoxicity has been reported in recipients of solid organ and bone marrow transplants. These neurological side effects are usually mild and resolve with temporary reduction or withdrawal of CsA. We report a 16-year-old renal transplant recipient who developed tremor, tinnitus, and peripheral facial paralysis during oral CsA treatment. Her serum magnesium level was below the normal range and her peripheral facial paralysis did not improve with the cessation of the drug.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Cyclosporine / adverse effects*
  • Cyclosporine / blood
  • Facial Paralysis / chemically induced*
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / blood
  • Kidney Transplantation*

Substances

  • Immunosuppressive Agents
  • Cyclosporine